Lv6
2030 积分 2023-09-12 加入
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
3个月前
已完结
CRISPR-Based Therapy for Hereditary Angioedema
7个月前
已完结
CD19, from bench to bedside
8个月前
已完结
Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling
8个月前
已完结
High-multiplex single-cell imaging analysis reveals tumor immune contexture associated with clinical outcomes after CAR T-cell therapy
8个月前
已完结
Axicabtagene Ciloleucel in Large B-Cell Lymphoma
9个月前
已完结
Phase II, Open-Label Study of Ciltacabtagene Autoleucel, an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor–T-Cell Therapy, in Chinese Patients With Relapsed/Refractory Multiple Myeloma (CARTIFAN-1)
9个月前
已完结
抗中性粒细胞胞质抗体相关血管炎诊疗规范
9个月前
已完结
Contemporary Management of Acute Myeloid Leukemia
9个月前
已完结
Off-the-shelf, gene-edited CAR-T cells forge ahead, despite safety scare
1年前
已完结
皖公网安备34019202002308
